Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Eicosapentaenoic acid/docosahexaenoic acid (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Acronyms Aim 2
- 11 Apr 2019 Biomarkers information updated
- 12 Oct 2012 New trial record